APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dupilumab Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Dupilumab Drug Market Outlook and Growth Opportunities 2026

23 December 2025198 pages

Choose your research edition.

Industry ResearchDupilumab Drug Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Dupilumab Drug Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Dupilumab Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dupilumab Drug Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Dupilumab Drug Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Dupilumab Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Dupilumab Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dupilumab Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dupilumab Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Dupilumab Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Dupilumab Drug market include Sanofi, Swixx Biopharma, Amicus Llc and ABACUS MEDICINE, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dupilumab Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dupilumab Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dupilumab Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dupilumab Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Dupilumab Drug Segment by Company

Sanofi

Swixx Biopharma

Amicus Llc

ABACUS MEDICINE

Dupilumab Drug Segment by Type

200mg (1.14mL)/Vial

300mg (2.0 mL)/Vial

Dupilumab Drug Segment by Application

Hospitals

Retail Pharmacy

Others

Dupilumab Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Dupilumab Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Dupilumab Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Dupilumab Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Dupilumab Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dupilumab Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dupilumab Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dupilumab Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dupilumab Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dupilumab Drug industry.

Chapter 3: Detailed analysis of Dupilumab Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Dupilumab Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Dupilumab Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Dupilumab Drug Industry Trends Table 2. Dupilumab Drug Industry Drivers Table 3. Dupilumab Drug Industry Opportunities and Challenges Table 4. Dupilumab Drug Industry Restraints Table 5. Global Dupilumab Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Dupilumab Drug Revenue Share by Company (2021-2026) Table 7. Global Dupilumab Drug Sales Volume by Company (k units) & (2021-2026) Table 8. Global Dupilumab Drug Sales Volume Share by Company (2021-2026) Table 9. Global Dupilumab Drug Average Price (USD/unit) of Company (2021-2026) Table 10. Global Dupilumab Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Dupilumab Drug Key Company Manufacturing Base & Headquarters Table 12. Global Dupilumab Drug Company, Product Type & Application Table 13. Global Dupilumab Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Dupilumab Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 200mg (1.14mL)/Vial Table 18. Significant Companies of 300mg (2.0 mL)/Vial Table 19. Global Dupilumab Drug Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Dupilumab Drug Sales Volume by Type (2021-2026) & (k units) Table 21. Global Dupilumab Drug Sales Volume by Type (2027-2032) & (k units) Table 22. Global Dupilumab Drug Sales Volume Share by Type (2021-2026) Table 23. Global Dupilumab Drug Sales Volume Share by Type (2027-2032) Table 24. Global Dupilumab Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Dupilumab Drug Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Dupilumab Drug Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Dupilumab Drug Sales Value Share by Type (2021-2026) Table 28. Global Dupilumab Drug Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospitals Table 30. Significant Companies of Retail Pharmacy Table 31. Significant Companies of Others Table 32. Global Dupilumab Drug Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Dupilumab Drug Sales Volume by Application (2021-2026) & (k units) Table 34. Global Dupilumab Drug Sales Volume by Application (2027-2032) & (k units) Table 35. Global Dupilumab Drug Sales Volume Share by Application (2021-2026) Table 36. Global Dupilumab Drug Sales Volume Share by Application (2027-2032) Table 37. Global Dupilumab Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Dupilumab Drug Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Dupilumab Drug Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Dupilumab Drug Sales Value Share by Application (2021-2026) Table 41. Global Dupilumab Drug Sales Value Share by Application (2027-2032) Table 42. Global Dupilumab Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Dupilumab Drug Sales by Region (2021-2026) & (k units) Table 44. Global Dupilumab Drug Sales Market Share by Region (2021-2026) Table 45. Global Dupilumab Drug Sales by Region (2027-2032) & (k units) Table 46. Global Dupilumab Drug Sales Market Share by Region (2027-2032) Table 47. Global Dupilumab Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Dupilumab Drug Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Dupilumab Drug Sales Value Share by Region (2021-2026) Table 50. Global Dupilumab Drug Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Dupilumab Drug Sales Value Share by Region (2027-2032) Table 52. Global Dupilumab Drug Market Average Price (USD/unit) by Region (2021-2026) Table 53. Global Dupilumab Drug Market Average Price (USD/unit) by Region (2027-2032) Table 54. Global Dupilumab Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Dupilumab Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Dupilumab Drug Sales by Country (2021-2026) & (k units) Table 57. Global Dupilumab Drug Sales Market Share by Country (2021-2026) Table 58. Global Dupilumab Drug Sales by Country (2027-2032) & (k units) Table 59. Global Dupilumab Drug Sales Market Share by Country (2027-2032) Table 60. Global Dupilumab Drug Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Dupilumab Drug Sales Value Market Share by Country (2021-2026) Table 62. Global Dupilumab Drug Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Dupilumab Drug Sales Value Market Share by Country (2027-2032) Table 64. Sanofi Company Information Table 65. Sanofi Business Overview Table 66. Sanofi Dupilumab Drug Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 67. Sanofi Dupilumab Drug Product Portfolio Table 68. Sanofi Recent Development Table 69. Swixx Biopharma Company Information Table 70. Swixx Biopharma Business Overview Table 71. Swixx Biopharma Dupilumab Drug Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 72. Swixx Biopharma Dupilumab Drug Product Portfolio Table 73. Swixx Biopharma Recent Development Table 74. Amicus Llc Company Information Table 75. Amicus Llc Business Overview Table 76. Amicus Llc Dupilumab Drug Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. Amicus Llc Dupilumab Drug Product Portfolio Table 78. Amicus Llc Recent Development Table 79. ABACUS MEDICINE Company Information Table 80. ABACUS MEDICINE Business Overview Table 81. ABACUS MEDICINE Dupilumab Drug Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. ABACUS MEDICINE Dupilumab Drug Product Portfolio Table 83. ABACUS MEDICINE Recent Development Table 84. Key Raw Materials Table 85. Raw Materials Key Suppliers Table 86. Dupilumab Drug Distributors List Table 87. Dupilumab Drug Customers List Table 88. Research Programs/Design for This Report Table 89. Authors List of This Report Table 90. Secondary Sources Table 91. Primary Sources List of Figures Figure 1. Dupilumab Drug Product Image Figure 2. Global Dupilumab Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dupilumab Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Dupilumab Drug Sales (2021-2032) & (k units) Figure 5. Global Dupilumab Drug Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Dupilumab Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 200mg (1.14mL)/Vial Image Figure 10. 300mg (2.0 mL)/Vial Image Figure 11. Global Dupilumab Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Dupilumab Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Dupilumab Drug Sales Volume Share by Type (2021-2032) Figure 14. Global Dupilumab Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Dupilumab Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Dupilumab Drug Sales Value Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Retail Pharmacy Image Figure 19. Others Image Figure 20. Global Dupilumab Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Dupilumab Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Dupilumab Drug Sales Volume Share by Application (2021-2032) Figure 23. Global Dupilumab Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Dupilumab Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Dupilumab Drug Sales Value Share by Application (2021-2032) Figure 26. Global Dupilumab Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Dupilumab Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Dupilumab Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Dupilumab Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Dupilumab Drug Sales Value (2021-2032) & (US$ Million) Figure 31. North America Dupilumab Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Dupilumab Drug Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Dupilumab Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Dupilumab Drug Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Dupilumab Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Dupilumab Drug Sales Value (2021-2032) & (US$ Million) Figure 37. South America Dupilumab Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Dupilumab Drug Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Dupilumab Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Dupilumab Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Dupilumab Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Dupilumab Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Dupilumab Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Dupilumab Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Dupilumab Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Dupilumab Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Dupilumab Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Dupilumab Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Dupilumab Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Dupilumab Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Dupilumab Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Dupilumab Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Dupilumab Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Dupilumab Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Dupilumab Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Dupilumab Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Dupilumab Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Dupilumab Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Dupilumab Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Dupilumab Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Dupilumab Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Dupilumab Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Dupilumab Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Dupilumab Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Dupilumab Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Dupilumab Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Dupilumab Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Dupilumab Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Dupilumab Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Dupilumab Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Dupilumab Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Dupilumab Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Dupilumab Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Dupilumab Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Dupilumab Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Dupilumab Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Dupilumab Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Dupilumab Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Dupilumab Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Dupilumab Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Dupilumab Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Dupilumab Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Dupilumab Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Dupilumab Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Dupilumab Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Dupilumab Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Dupilumab Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Dupilumab Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Dupilumab Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Dupilumab Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Dupilumab Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Dupilumab Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Dupilumab Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Dupilumab Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Dupilumab Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Dupilumab Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Dupilumab Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Dupilumab Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Dupilumab Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Dupilumab Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Dupilumab Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Dupilumab Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Dupilumab Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Dupilumab Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Dupilumab Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Dupilumab Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Dupilumab Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Dupilumab Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Dupilumab Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Dupilumab Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Dupilumab Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Dupilumab Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Dupilumab Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Dupilumab Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Dupilumab Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Dupilumab Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Dupilumab Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Dupilumab Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Dupilumab Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Dupilumab Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Dupilumab Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Dupilumab Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Dupilumab Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Dupilumab Drug Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Dupilumab Drug Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 200mg (1.14mL)/Vial
  • 300mg (2.0 mL)/Vial
Applications
  • Hospitals
  • Retail Pharmacy
  • Others
Companies covered
  • Sanofi
  • Swixx Biopharma
  • Amicus Llc
  • ABACUS MEDICINE

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dupilumab Drug Sales Value (2021-2032)
  4. 1.2.2 Global Dupilumab Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Dupilumab Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Dupilumab Drug Market Dynamics
  1. 2.1 Dupilumab Drug Industry Trends
  2. 2.2 Dupilumab Drug Industry Drivers
  3. 2.3 Dupilumab Drug Industry Opportunities and Challenges
  4. 2.4 Dupilumab Drug Industry Restraints
3 Dupilumab Drug Market by Company
  1. 3.1 Global Dupilumab Drug Company Revenue Ranking in 2025
  2. 3.2 Global Dupilumab Drug Revenue by Company (2021-2026)
  3. 3.3 Global Dupilumab Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Dupilumab Drug Average Price by Company (2021-2026)
  5. 3.5 Global Dupilumab Drug Company Ranking (2024-2026)
  6. 3.6 Global Dupilumab Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Dupilumab Drug Company Product Type and Application
  8. 3.8 Global Dupilumab Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Dupilumab Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Dupilumab Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Dupilumab Drug Market by Type
  1. 4.1 Dupilumab Drug Type Introduction
  2. 4.1.1 200mg (1.14mL)/Vial
  3. 4.1.2 300mg (2.0 mL)/Vial
  4. 4.2 Global Dupilumab Drug Sales Volume by Type
  5. 4.2.1 Global Dupilumab Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Dupilumab Drug Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Dupilumab Drug Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Dupilumab Drug Sales Value by Type
  9. 4.3.1 Global Dupilumab Drug Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Dupilumab Drug Sales Value by Type (2021-2032)
  11. 4.3.3 Global Dupilumab Drug Sales Value Share by Type (2021-2032)
5 Dupilumab Drug Market by Application
  1. 5.1 Dupilumab Drug Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 Others
  5. 5.2 Global Dupilumab Drug Sales Volume by Application
  6. 5.2.1 Global Dupilumab Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dupilumab Drug Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Dupilumab Drug Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Dupilumab Drug Sales Value by Application
  10. 5.3.1 Global Dupilumab Drug Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Dupilumab Drug Sales Value by Application (2021-2032)
  12. 5.3.3 Global Dupilumab Drug Sales Value Share by Application (2021-2032)
6 Dupilumab Drug Regional Sales and Value Analysis
  1. 6.1 Global Dupilumab Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dupilumab Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Dupilumab Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Dupilumab Drug Sales by Region (2027-2032)
  5. 6.3 Global Dupilumab Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Dupilumab Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Dupilumab Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Dupilumab Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Dupilumab Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Dupilumab Drug Sales Value (2021-2032)
  12. 6.6.2 North America Dupilumab Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Dupilumab Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Dupilumab Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Dupilumab Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Dupilumab Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Dupilumab Drug Sales Value (2021-2032)
  21. 6.9.2 South America Dupilumab Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Dupilumab Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Dupilumab Drug Sales Value Share by Country, 2025 VS 2032
7 Dupilumab Drug Country-level Sales and Value Analysis
  1. 7.1 Global Dupilumab Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Dupilumab Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Dupilumab Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Dupilumab Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Dupilumab Drug Sales by Country (2027-2032)
  6. 7.4 Global Dupilumab Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Dupilumab Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Dupilumab Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Dupilumab Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Dupilumab Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Dupilumab Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Dupilumab Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Dupilumab Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Dupilumab Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Dupilumab Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Dupilumab Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Dupilumab Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Dupilumab Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Dupilumab Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Dupilumab Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Dupilumab Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Dupilumab Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Dupilumab Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Dupilumab Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Dupilumab Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Dupilumab Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Dupilumab Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Dupilumab Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Dupilumab Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Dupilumab Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Dupilumab Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Dupilumab Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Dupilumab Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Dupilumab Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Dupilumab Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Dupilumab Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Dupilumab Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Dupilumab Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Dupilumab Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Dupilumab Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Dupilumab Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Dupilumab Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Dupilumab Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Dupilumab Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Dupilumab Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Dupilumab Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Dupilumab Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Dupilumab Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Dupilumab Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Dupilumab Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Dupilumab Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Dupilumab Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Dupilumab Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Dupilumab Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Dupilumab Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Dupilumab Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Dupilumab Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Dupilumab Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Dupilumab Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Dupilumab Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Dupilumab Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Dupilumab Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Dupilumab Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Dupilumab Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Dupilumab Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Dupilumab Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Dupilumab Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Dupilumab Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Dupilumab Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Dupilumab Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Dupilumab Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Dupilumab Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Dupilumab Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Dupilumab Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Dupilumab Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Dupilumab Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Dupilumab Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Dupilumab Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Dupilumab Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Dupilumab Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Dupilumab Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Dupilumab Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Dupilumab Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Dupilumab Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Dupilumab Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Dupilumab Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Dupilumab Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Dupilumab Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Dupilumab Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Dupilumab Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Dupilumab Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Dupilumab Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Dupilumab Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Dupilumab Drug Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Swixx Biopharma
  8. 8.2.1 Swixx Biopharma Company Information
  9. 8.2.2 Swixx Biopharma Business Overview
  10. 8.2.3 Swixx Biopharma Dupilumab Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Swixx Biopharma Dupilumab Drug Product Portfolio
  12. 8.2.5 Swixx Biopharma Recent Developments
  13. 8.3 Amicus Llc
  14. 8.3.1 Amicus Llc Company Information
  15. 8.3.2 Amicus Llc Business Overview
  16. 8.3.3 Amicus Llc Dupilumab Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Amicus Llc Dupilumab Drug Product Portfolio
  18. 8.3.5 Amicus Llc Recent Developments
  19. 8.4 ABACUS MEDICINE
  20. 8.4.1 ABACUS MEDICINE Company Information
  21. 8.4.2 ABACUS MEDICINE Business Overview
  22. 8.4.3 ABACUS MEDICINE Dupilumab Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 ABACUS MEDICINE Dupilumab Drug Product Portfolio
  24. 8.4.5 ABACUS MEDICINE Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dupilumab Drug Value Chain Analysis
  2. 9.1.1 Dupilumab Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dupilumab Drug Sales Mode & Process
  6. 9.2 Dupilumab Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dupilumab Drug Distributors
  9. 9.2.3 Dupilumab Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst